Dan Leblanc
Nessuna posizione attualmente
Profilo
Dan Leblanc worked as a Director of Pharmaceutical Development at Merck Serono SA and as a Senior Vice President of CMC Operations at Flexion Therapeutics, Inc. He holds a graduate degree from The Wharton School of the University of Pennsylvania and an undergraduate degree from the School of Engineering & Applied Science.
Precedenti posizioni note di Dan Leblanc
| Società | Posizione | Fine |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2020 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | - |
Formazione di Dan Leblanc
| School of Engineering & Applied Science | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Dan Leblanc
